Skip to content

Quick Access

Contact Us

Search

What can we help you find?

Site Navigation

Access FMT
- Clinical
  - Investigational FMT for C. difficile
  - FMT for Clinical Research
- Non-clinical Research
- Investigational FMT Access
- Research
  - Non-Clinical
- Microbiome Conservation
- Biobanking
- Global Health
Join Us
Media

Our Insights

We’ve built this living repository to share our expertise on the microbiome and investigational fecal microbiota transplantation (FMT). This digital library contains white papers and academic publications describing the knowledge gleaned from treating more than 64,000 patients with investigational FMT preparations and collaborating on more than 40 clinical trials across 30 disease indications.

openbiome_11_17_22_4203

Our Publication Highlights

Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study
-A key OpenBiome publication
An omics-based framework for assessing the health risk of antimicrobial resistance genes
- Research from our expanded global mission & new flagship program
Use of Fecal Microbial Transplantation for Immune Checkpoint Inhibitor Colitis
-OpenBiome partners with clinicians to investigate FMT as a treatment for a variety of diseases
Fecal Microbiota Transplantation: An Introduction to FMT, its History, and Therapeutic Potential
-An introduction to FMT from our collection of White Papers

New & Noteworthy

2023

Fecal Microbiota Transplantation For Clostridioides Difficile Infection In Immunocompromised Pediatric Patients Opens a new window

2023

Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation Opens a new window

Refine Search

Clear All

Programs

FMT Access
GMbC

Type

Academic Publication
Annual Report
White Paper

Theme

BioBanking
C. Difficile
Conducting Research
Diet
Drug Development
FMT Clinical Trials
FMT Safety And Access
Immune System
Infectious Disease
Inflammatory Bowel Disease
Intro to FMT
Liver Disease
Metabolic Disorders
Microbiome Diversity
Neuropsychiatric/development Disorders
OpenBiome

Search

Start A Collaboration

Have an idea for a study or publication? We’d love to hear from you and discuss how to get involved.

Let's Connect

The OpenBiome Outreach Team

info@openbiome.org

Footer

Get Our Emails

Your Name

Your Email (Required) *

Connect with us

Helpful Links

Our Mission and Story

Latest Features

Global Microbiome Conservancy (GMbC)

FMT For Patients

FMT For Clinicians

Get Involved

Let’s Connect

info@openbiome.org

phone: (617) 575-2201
fax: (617) 575-2201

The investigational fecal microbiota transplantation (FMT) treatments discussed on this website and associated OpenBiome materials have been not been approved or licensed by the U.S. Food and Drug Administration or by any other regulatory authority, and it is not commercially available in any market. OpenBiome is acting only in the capacity of distributor of investigational FMT preparations manufactured by the University of Minnesota under an FDA-reviewed investigational new drug application (IND).

Before placing an order for any investigational FMT from OpenBiome/UMN, a licensed physician must submit a registration form, agree to comply with applicable regulatory requirements intended to safeguard the patients under their care, and be added as an investigator to the research IND that authorizes expanded access to the investigational biologic for appropriate patients.

©OpenBiome 2022, 501(c)(3) not-for-profit organization

Scroll To Top